Chaguturu Sreekanth K 4
4 · CVS HEALTH Corp · Filed Feb 14, 2024
Insider Transaction Report
Form 4
Chaguturu Sreekanth K
EVP and Chief Medical Officer
Transactions
- Award
Common Stock
2024-02-12+1,926→ 8,645.187 total
Holdings
- 21,972
Common Stock (Restricted)
- 5,952
Stock Option
Exercise: $75.27From: 2020-11-29Exp: 2029-11-29→ Common Stock (5,952 underlying) - 9,579
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (9,579 underlying) - 9,502
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (9,502 underlying) - 12,993
Stock Option
Exercise: $101.09From: 2023-04-01Exp: 2032-04-01→ Common Stock (12,993 underlying) - 40,825
Stock Option
Exercise: $74.31From: 2024-04-01Exp: 2033-04-01→ Common Stock (40,825 underlying)
Footnotes (6)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on April 1, 2021. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 12, 2024.
- [F2]Option became exercisable in four equal annual installments, commencing 11/29/2020.
- [F3]Option became exercisable in four equal annual installments, commencing 4/1/2021.
- [F4]Option became exercisable in four equal annual installments, commencing 4/1/2022.
- [F5]Option became exercisable in four equal annual installments, commencing 4/1/2023.
- [F6]Option becomes exercisable in four equal annual installments, commencing 4/1/2024.